Reaction
Palliative Care reporting signals
As of the last recalculation, Palliative Care appears in 1,512 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is LANREOTIDE ACETATE (PRR 39.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lanreotide Acetate | 22 | 39.2 | 39.3 |
| Leuprolide Acetate | 191 | 38.7 | 38.7 |
| Darbepoetin Alfa | 101 | 27.6 | 27.6 |
| Azacitidine For | 31 | 23.9 | 24.0 |
| Rasagiline Mesylate | 17 | 21.3 | 21.3 |
| Remdesivir | 19 | 19.9 | 19.9 |
| Venetoclax | 76 | 17.8 | 17.9 |
| Azacitidine | 33 | 15.6 | 15.6 |
| Bicalutamide | 16 | 14.6 | 14.6 |
| Sennosides 8.6 Mg Tablets | 17 | 11.3 | 11.3 |
| Senna | 17 | 11.2 | 11.2 |
| Senna Leaf | 17 | 10.2 | 10.3 |
| Rotigotine | 10 | 9.6 | 9.6 |
| Clozapine | 82 | 9.4 | 9.5 |
| Rivastigmine | 12 | 8.8 | 8.8 |
| Lapatinib | 8 | 7.1 | 7.1 |
| Apalutamide | 6 | 7.0 | 7.1 |
| Carbidopa And Levodopa | 23 | 6.8 | 6.8 |
| Carfilzomib | 12 | 5.9 | 5.9 |
| Tafamidis | 4 | 4.7 | 4.7 |
| Denosumab | 66 | 4.6 | 4.6 |
| Pazopanib Hydrochloride | 9 | 4.6 | 4.6 |
| Abiraterone Acetate | 11 | 3.7 | 3.7 |
| Pirfenidone | 10 | 3.4 | 3.4 |
| Pimavanserin Tartrate | 6 | 1.5 | 1.5 |